fenofibrate and tyrosine

fenofibrate has been researched along with tyrosine in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's11 (64.71)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Brundel, BJ; Burstein, B; Leung, TK; Mitamura, H; Nattel, S; Ogawa, S; Shiroshita-Takeshita, A1
Besson, VC; Chen, XR; Garcia, Y; Marchand-Leroux, C; Palmier, B; Plotkine, M1
Chen, YJ; Quilley, J1
Chen, YJ; Li, J; Quilley, J1
Cwinn, MA; Jones, SP; Kennedy, SW1
Aburatani, H; Doi, T; Hamakubo, T; Ishimoto, K; Kawabe, N; Kodama, T; Nakamura, H; Sakai, J; Tachibana, K; Tanaka, T; Yamasaki, D1
Asavapanumas, N; Chatsudthipong, V; Kittayaruksakul, S; Meetam, P; Muanprasat, C; Soodvilai, S1
Ji, M; Li, Y; Lin, Q; Lin, R; Ren, F; Wang, W; Zhang, J1
Chen, TH; Chiou, YL; Huang, YC; Li, TT; Liu, KC; Liu, LL; Yang, CH1
Bai, L; Ji, M; Lin, R; Lu, Y; Qiao, H; Ren, F; Wang, W; Yang, L; Zhang, J1
Cui, GB; Liu, L; Liu, YH; Ma, B; Sun, JJ; Wu, ZM; Xu, QY; Yang, ZD; Yao, D; Zhang, Q1
Chen, S; Huang, J; Huang, Q; Liu, B; Liu, P; Luo, J; Pan, X; Zang, L; Zeng, Z; Zhou, S1
Ann, SJ; Chung, JH; Jang, J; Kang, SM; Kim, SH; Lee, SH; Park, BH; Park, S1
Dong, JM; Dong, ZX; Hang, PZ; Hou, TT; Li, WM; Li, Y; Liu, GZ; Liu, Y; Liu, YW; Shi, H; Sun, L; Wang, XB; Yuan, Y; Zhan, CC; Zhao, GQ; Zhao, J; Zhao, JJ; Zhou, JH1
Kim, J; Lee, H; Lim, J; Shin, SS; Yang, H; Yoon, M; Yoon, S1
Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP1
Astakhova, AA; Chistyakov, DV; Goriainov, SV; Sergeeva, MG1

Other Studies

17 other study(ies) available for fenofibrate and tyrosine

ArticleYear
Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
    Cardiovascular research, 2007, Apr-01, Volume: 74, Issue:1

    Topics: Actins; Animals; Anti-Inflammatory Agents; Atrial Fibrillation; Biomarkers; Cardiac Pacing, Artificial; Cell Proliferation; Cells, Cultured; Dogs; Fenofibrate; Fibroblasts; Heart Atria; Heart Failure; Heart Ventricles; Hypolipidemic Agents; Models, Animal; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; PPAR alpha; Refractory Period, Electrophysiological; Simvastatin; Tyrosine; Ventricular Remodeling

2007
Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.
    Journal of neurotrauma, 2007, Volume: 24, Issue:7

    Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Brain Injuries; Cyclooxygenase 2; Encephalitis; Fenofibrate; Glutathione; Male; Matrix Metalloproteinase 9; Nitric Oxide Synthase Type II; Oxidative Stress; PPAR alpha; Rats; Rats, Sprague-Dawley; Recovery of Function; Treatment Outcome; Tyrosine

2007
Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:2

    Topics: Animals; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Fenofibrate; Gene Expression Regulation, Enzymologic; Kidney; Male; Prostaglandins; Rats; Rats, Wistar; Tyrosine

2008
Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5

    Topics: Aldehyde Reductase; Animals; Antioxidants; Arachidonic Acid; Benzothiazoles; Cyclic N-Oxides; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Enzyme Induction; Enzyme Inhibitors; Fenofibrate; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Indomethacin; Insulin; Kidney; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Perfusion; Phthalazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Spin Labels; Tyrosine

2008
Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2008, Volume: 148, Issue:2

    Topics: Alkanesulfonic Acids; Animals; Cell Survival; Cells, Cultured; Chick Embryo; Dose-Response Relationship, Drug; Environmental Pollutants; Fenofibrate; Fluorocarbons; Gene Expression Regulation, Enzymologic; Hepatocytes; Lipid Metabolism; Liver; Oxazoles; PPAR alpha; RNA, Messenger; Time Factors; Transcription, Genetic; Tyrosine

2008
Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms.
    European journal of cell biology, 2011, Volume: 90, Issue:8

    Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin-Dependent Kinase Inhibitor p27; DNA-Directed DNA Polymerase; E2F1 Transcription Factor; Fenofibrate; Flow Cytometry; Humans; Immunoblotting; Liver Neoplasms; Oxazoles; Phosphorylation; PPAR alpha; Proto-Oncogene Proteins c-akt; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Proteins; Tyrosine

2011
Fenofibrate down-regulates renal OCT2-mediated organic cation transport via PPARα-independent pathways.
    Drug metabolism and pharmacokinetics, 2012, Volume: 27, Issue:5

    Topics: Animals; Biological Transport; Cell Line; Cell Survival; CHO Cells; Cricetinae; Cycloheximide; Down-Regulation; Epithelial Cells; Fenofibrate; Hypolipidemic Agents; Kidney Cortex; Male; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxazoles; PPAR alpha; Pyrimidines; Rabbits; Swine; Tyrosine

2012
PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.
    Experimental cell research, 2013, Jun-10, Volume: 319, Issue:10

    Topics: 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Benzamides; Blotting, Western; CD40 Antigens; Fenofibrate; Mice; Naphthols; NF-kappa B; Niacinamide; Oxazoles; PPAR alpha; Pyrrolidines; RNA, Messenger; Signal Transduction; Sirtuin 1; Thiocarbamates; Tumor Necrosis Factor-alpha; Tyrosine

2013
Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.
    Chemico-biological interactions, 2013, Oct-05, Volume: 205, Issue:3

    Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Fenofibrate; Humans; Imidazoles; MAP Kinase Signaling System; Melanins; Melanoma, Experimental; Microphthalmia-Associated Transcription Factor; Oxazoles; PPAR alpha; Pyridines; Real-Time Polymerase Chain Reaction; RNA; Tyrosine

2013
The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells.
    Inflammation, 2014, Volume: 37, Issue:1

    Topics: Acetylation; Antioxidants; Benzamides; CD40 Antigens; Cells, Cultured; Fenofibrate; Human Umbilical Vein Endothelial Cells; Humans; Hypolipidemic Agents; Inflammation; Naphthols; Niacinamide; Oxazoles; PPAR alpha; Pyrrolidines; RNA Interference; RNA, Small Interfering; Signal Transduction; Sirtuin 1; Thiocarbamates; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation

2014
Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:10

    Topics: 3-Hydroxybutyric Acid; Animals; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Diet, High-Fat; Fenofibrate; Hyperlipidemias; Isoleucine; Linoleic Acid; Male; Metabolome; Metabolomics; Ornithine; Rats; Rats, Sprague-Dawley; Simvastatin; Tyrosine

2014
Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
    Life sciences, 2015, Mar-01, Volume: 124

    Topics: Animals; Animals, Newborn; Butyryl-CoA Dehydrogenase; Cardiomegaly; Disease Models, Animal; Fatty Acids; Fenofibrate; Flavonoids; Insulin-Like Growth Factor I; MAP Kinase Signaling System; Myocytes, Cardiac; Oxazoles; Phenylephrine; Phosphorylation; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction; Tyrosine

2015
PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1.
    Atherosclerosis, 2015, Volume: 240, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; beta-Defensins; Cell Line; Culture Media, Conditioned; Dose-Response Relationship, Drug; Fenofibrate; Gemfibrozil; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Oxazoles; PPAR alpha; RNA Interference; Signal Transduction; Toll-Like Receptor 4; Transfection; Tyrosine; Up-Regulation

2015
Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.
    British journal of pharmacology, 2016, Volume: 173, Issue:6

    Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Carbazoles; Cell Line; Fenofibrate; Heart Atria; Humans; Male; Middle Aged; Oxazoles; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rabbits; Sirtuin 1; Tyrosine

2016
The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Journal of ethnopharmacology, 2017, Jan-04, Volume: 195

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Biomarkers; Cytokines; Disease Models, Animal; Fenofibrate; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Hepatitis; Hepatocytes; Humans; Hypolipidemic Agents; Inflammation Mediators; Lipids; Lipogenesis; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Oxazoles; Plant Extracts; PPAR alpha; Rats, Inbred OLETF; RNA, Messenger; Transfection; Tyrosine

2017
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Neuropharmacology, 2017, 05-15, Volume: 118

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine

2017
Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes.
    International journal of molecular sciences, 2020, Dec-16, Volume: 21, Issue:24

    Topics: Anilides; Animals; Anti-Inflammatory Agents; Astrocytes; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Fenofibrate; Interleukin-10; Lipopolysaccharides; MAP Kinase Kinase 4; Oxazoles; Oxylipins; p38 Mitogen-Activated Protein Kinases; PPAR gamma; PPAR-beta; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Tumor Necrosis Factor-alpha; Tyrosine

2020